FibroGen (FGEN) Tops Q1 EPS by 8c ; Offers Guidance

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.33), $0.08 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $55.9 million versus the consensus estimate of $36.45 million.

GUIDANCE:

FibroGen sees FY2024 revenue of $120-135 million, versus the consensus of $155.3 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• SelectQuote, Inc. (SLQT) Misses Q4 EPS by 4c ; Offers Guidance
• Citi Trends (CTRN) Tops Q2 EPS by 24c
• Morgan Stanley Downgrades Nichirei Corp (2871:JP) to Equalweight